CannabisNewsBreaks

MondayJun 13, 2022 12:37 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX) GrowPods Address Food Security Issues

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies, provide an effective way for food to be produced locally, almost anywhere in the world, thus enhancing food security. According to the announcement, the pandemic and disruptions to the food supply chain have heavily effected food supply around the world, with growing numbers of communities experiencing empty shelves. Consequently, governments and community groups are searching for ways to increase food supplies. Modular hydroponic farms, such as ACTX’s GrowPods, are a viable option. The company noted that its GrowPods can…

Continue Reading

FridayJun 10, 2022 12:44 pm

CannabisNewsBreaks – Flora Growth Corp.’s (NASDAQ: FLGC) Completion of Key Milestones Position It for Success

Flora Growth Corp. (NASDAQ: FLGC) recently announced financial and operating results for the 2021 fiscal year that show the success of its efforts as revenues and profits begin what is expected to be a rapid climb. “The year-end financial results show about $9 million in revenues, which is ‘significantly higher’ than those reported the prior year before the law change and Flora’s IPO launch on the Nasdaq Capital Market. The report maintains the company’s outlook for ending 2022 with revenues of $35 million to $45 million, which would be growth of between 288% and 400% over 2021. Much of Flora’s…

Continue Reading

ThursdayJun 09, 2022 2:15 pm

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Portfolio of Rare Cannabinoids with Launch of d9-THCV

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announced its launch of B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly owned subsidiary, BayMedica LLC. “We are very excited to launch our highly anticipated d9-THCV and further enhance BayMedica’s growing product portfolio,” said Shane Johnson, MD, SVP and general manager of BayMedica. “THCV is one of the few rare cannabinoids that has been researched in early clinical trials for various therapeutic effects, fueling significant interest by end-product manufacturers and consumers alike.…

Continue Reading

WednesdayJun 08, 2022 12:26 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Grants DehydraTECH(TM) License to Ireland-Based AnodGen Bioceuticals

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced the awarding of a five-year, non-exclusive DehydraTECH(TM) license from its wholly-owned subsidiary, Lexaria Pharmaceutical Corp., to AnodGen Bioceuticals of Ireland. According to the update, the awarded license is valid for the manufacturing and distribution of DehydraTECH-processed cannabinoid active pharmaceutical ingredient (“API”) powders within Europe including the U.K., Australia and New Zealand; including pharmaceutical and medical product applications for psychoactive cannabinoids and medical product applications for non-psychoactive cannabinoids. AnodGen, which has the right to manufacture and sell these API powders to third party companies for their own…

Continue Reading

TuesdayJun 07, 2022 10:16 am

CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Closes $5M Direct, Private Placement Offerings

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, has closed on its registered direct offering and concurrent private placement with a single healthcare-focused institutional investor; the offerings were priced at-the-market under Nasdaq rules. According to the announcement, for the registered direct offering, INM issued 4,079,256 common shares at a purchase price of $0.858 per share (or prefunded warrant in lieu thereof). For the concurrent private placement, InMed issued and sold to the investor 1,748,250 common shares (or prefunded warrant in lieu thereto); those shares were offered at the same purchase price as…

Continue Reading

MondayJun 06, 2022 2:15 pm

CannabisNewsBreaks – Advanced Container Technologies Inc. (ACTX), Growpods Spotlighted in Borgen Magazine Article

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies, were featured in an article published in Borgen magazine. The article, titled “How GrowPods Are Aiding Global Food Security,” notes that ACTX’s GrowPods “have the potential to help achieve global food security.” Noting that the consequences of global food insecurity are enormous, the article reports that Advanced Container Technologies and the innovative GrowPods may help solve the issue of global food shortages. Because the modular hydroponic farms can be located anywhere and provide an easily, accessible way to grow…

Continue Reading

MondayJun 06, 2022 2:08 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Takes First Regulatory Step with FDA for Development of DehydraTECH-CBD in Treating Hypertension

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has successfully filed a pre-Investigational New Drug (“IND”) meeting request letter with the U.S. Food and Drug Administration (“FDA”). According to the update, the FDA has already responded to and confirmed Lexaria’s filing and has provided a target date of July 30, 2022, subject to certain conditions being met. “We are excited to take this important first regulatory step with the FDA for the development of our DehydraTECH-CBD for the treatment of hypertension,” said John Docherty, president of Lexaria. “Submission of this request letter…

Continue Reading

FridayJun 03, 2022 3:32 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) Innovative Growing Systems Offering Numerous Advantages

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, is seeing interest in the environmentally controlled micro-farms that allow cultivation of ultraclean crops year-round. According to a recent article that contains excerpts from a GreenBiz piece titled, “How Vertical and Indoor Farming Can Supplement the Food Supply Chain,” innovators have developed new technologies such as indoor and vertical farms designed to supplement outdoor farming and solve the issue of limited cultivation land. The piece notes that “the systems often recirculate water, which can be more efficient than how water is used for other types of crops. Light and…

Continue Reading

FridayJun 03, 2022 2:29 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Awards Exclusive License to Japan’s Premier Wellness Science Co.

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in Japan to Premier Wellness Science Co. Ltd, a wholly owned subsidiary of Premier Anti-Aging Co. Ltd. LEXX announced that Premier is purchasing exclusive rights to DehydraTECH technology for the Japanese nonpharmaceutical market; the company will use the tech in oral liquid and nonliquid products, as well as for topical, hair-care, lip-care and cosmetics products. According to the announcement, Lexaria will receive minimum payments of $4,527,500 over the next five years, as all well as royalties from the sales of products…

Continue Reading

ThursdayJun 02, 2022 2:05 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH Footprint Extends to Europe with License Granted to Valcon Medical

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has awarded licensing of its proprietary DehydraTECH(TM) offering for development in the European and United Kingdom markets. The company awarded the nonexclusive licenses to Valcon Medical A/S, a European contract manufacturing organization that specializes in the manufacturing of medical cannabis extracts for the EU and UK. According to the announcement, Lexaria will receive milestone fees and royalty payments from sales of products manufactured by Valcon.Valcon products will include an array of options, from nonregistered medical products through magistral programs to country-level market-authorized medical cannabis products through pilot programs; they will…

Continue Reading